Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (351-360 of 536) with videos related to

Pageof 54
Sort By:
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
Analytical Chemistry|October 10, 2013
Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beaconsYun Wu, Kwang Joo Kwak, Kitty Agarwal, et al.
Blood|March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsSumithira Vasu, Shun He, Carolyn Cheney, et al.
Blood|June 8, 2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasNicholas A Zorko, Kelsie M Bernot, Susan P Whitman, et al.
Blood Advances|April 4, 2019
Leflunomide regulates c-Myc expression in myeloma cells through PIM targetingRalf Buettner, Corey Morales, Enrico Caserta, et al.
British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.
Blood|September 6, 2008
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cellsRosa Lapalombella, Bo Yu, Georgia Triantafillou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell TransplantationMonzr M Al Malki, Nitya Nathwani, Dongyun Yang, et al.
JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B studyHeiko Becker, Guido Marcucci, Kati Maharry, et al.
Pageof 54

Showing results (351-360 of 536) with videos related to

Sort By:
Pageof 54
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
Analytical Chemistry|October 10, 2013
Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beaconsYun Wu, Kwang Joo Kwak, Kitty Agarwal, et al.
Blood|March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsSumithira Vasu, Shun He, Carolyn Cheney, et al.
Blood|June 8, 2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasNicholas A Zorko, Kelsie M Bernot, Susan P Whitman, et al.
Blood Advances|April 4, 2019
Leflunomide regulates c-Myc expression in myeloma cells through PIM targetingRalf Buettner, Corey Morales, Enrico Caserta, et al.
British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.
Blood|September 6, 2008
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cellsRosa Lapalombella, Bo Yu, Georgia Triantafillou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell TransplantationMonzr M Al Malki, Nitya Nathwani, Dongyun Yang, et al.
JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B studyHeiko Becker, Guido Marcucci, Kati Maharry, et al.
Pageof 54